comparemela.com

Latest Breaking News On - Good health cant wait - Page 7 : comparemela.com

Dr Reddy Laboratories : Reddy s enters the trade generics business in India

Dr. Reddy s enters the trade generics business in India · Launches dedicated trade generics division within its India business called RGenX .

Andhra pradeshUnited statesReddy laboratories ltdExchange commissionGood health cant waitChief executive officerEmerging marketsGood health cant waitSustainability reportBanjara hillsAnnual report

Dr Reddy Laboratories : announces filing of Annual Report on Form 20-F - Form 6-K

Dr. Reddy s Laboratories Limited announces filing of Annual Report on Form 20-F Hyderabad, India, June 14, 2023 . | June 14, 2023

Andhra pradeshUnited statesReddy laboratories limitedExchange commission onReddy laboratoriesInternational financial reporting standardsInternational accounting standards boardGood health cant waitExchange commissionReddy laboratories ltdLaboratories limitedAnnual reportUnited states securitiesDepositary receiptsGood health cant waitSustainability report

Dr Reddy s Successfully Completes Phase I Study (IV Route) of DRL_TC, a Proposed Biosimilar of Tocilizumab

Tocilizumab is an important anti-rheumatic agent used in the treatment of adult patients with moderate to severe active rheumatoid arthritis who have had an inadequate response to one or more. | June 5, 2023

United statesAndhra pradeshReddy tocilizumabJayanth sridharTocilizumab roactemraTocilizumab actemraReddy laboratories ltdExchange commissionChugai seiyaku kabushiki kaisha corpGood health cant waitRoche groupDouble blindComparative pharmacokineticPharmacodynamic studyReference tocilizumabIntravenous route

Sub: Transcript of the Earnings call conducted on May 10, 2023 - Form 6-K

Sub: Transcript of the Earnings call conducted on May 10, 2023 Pursuant to Regulation 30 of Securities and Exchange Board of India Regulations, 2015, please find enclosed the. | May 16, 2023

New zealandUnited statesUnited kingdomDamayanti keraiParag agawwalAshish thavkarAnkush mahajanSurya patraKunal dhameshaCyndrella carvalhoTushar manudhaneK randhir singhRicha periwalPrakash agarwalMayne pharmaNitin agarwal

Junshi Biosciences Announces Collaboration with Dr Reddy s to Develop and Commercialize Toripalimab in 21 Countries

SHANGHAI, China, May 07, 2023 Shanghai Junshi Biosciences Co., Ltd announced a collaboration with Dr. Reddy’s Laboratories Limited to develop and commercialize toripalimab, the anti-PD-1. | May 7, 2023

United kingdomNew zealandSouth africaAndhra pradeshUnited statesSan franciscoZhi liJunshi biosciencesJunshi bioscienceNational stock exchange of indiaYork stock exchangeGood health cant waitIr teamNational reimbursement drug listBombay stock exchangePr team

vimarsana © 2020. All Rights Reserved.